EE9900034A - Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine - Google Patents
Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamineInfo
- Publication number
- EE9900034A EE9900034A EEP199900034A EE9900034A EE9900034A EE 9900034 A EE9900034 A EE 9900034A EE P199900034 A EEP199900034 A EE P199900034A EE 9900034 A EE9900034 A EE 9900034A EE 9900034 A EE9900034 A EE 9900034A
- Authority
- EE
- Estonia
- Prior art keywords
- arylcycloalkanecarboxylic
- esters
- preparation
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/12—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9602887A SE9602887D0 (sv) | 1996-07-29 | 1996-07-29 | Carboxylic esters, their use and preparation |
| SE9602890A SE9602890D0 (sv) | 1996-07-29 | 1996-07-29 | Carboxylic esters, their use and preparation |
| SE9602889A SE9602889D0 (sv) | 1996-07-29 | 1996-07-29 | Carboxylic esters, their use and preparation |
| SE9602888A SE9602888D0 (sv) | 1996-07-29 | 1996-07-29 | Carboxylic esters, their use and preparation |
| PCT/SE1997/001310 WO1998004517A1 (en) | 1996-07-29 | 1997-07-23 | Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900034A true EE9900034A (et) | 1999-08-16 |
Family
ID=27484794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900034A EE9900034A (et) | 1996-07-29 | 1997-07-23 | Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6124354A (zh) |
| EP (1) | EP0923536A1 (zh) |
| JP (1) | JP2000515881A (zh) |
| KR (1) | KR20000029703A (zh) |
| CN (1) | CN1226886A (zh) |
| AU (1) | AU724563B2 (zh) |
| BG (1) | BG103207A (zh) |
| BR (1) | BR9710614A (zh) |
| CA (1) | CA2261692A1 (zh) |
| EE (1) | EE9900034A (zh) |
| IL (1) | IL128096A0 (zh) |
| NO (1) | NO990335L (zh) |
| NZ (1) | NZ333798A (zh) |
| PL (1) | PL331384A1 (zh) |
| SK (1) | SK4699A3 (zh) |
| TR (1) | TR199900185T2 (zh) |
| WO (1) | WO1998004517A1 (zh) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
| US20030144352A1 (en) * | 2001-11-05 | 2003-07-31 | Cammarata Sue K. | Antimuscarinic aerosol |
| AU2004206846B2 (en) * | 2003-01-16 | 2009-05-28 | University Of Rochester | Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
| WO2008059239A1 (en) * | 2006-11-14 | 2008-05-22 | Astrazeneca Ab | Novel compounds 514 |
| EA017627B1 (ru) | 2008-05-13 | 2013-01-30 | Астразенека Аб | Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора |
| BRPI0912657A2 (pt) * | 2008-05-13 | 2016-01-26 | Astrazeneca Ab | produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista beta2-adrenorreceptor |
| WO2012145234A2 (en) * | 2011-04-21 | 2012-10-26 | Emory University | Cyclopropyl derivatives and methods of use |
| JOP20130273B1 (ar) | 2012-09-11 | 2021-08-17 | Genzyme Corp | مثبطات انزيم (سينثاز) غلوكوسيل سيراميد |
| TW201517906A (zh) | 2013-07-25 | 2015-05-16 | Almirall Sa | 含有ｍａｂａ化合物和皮質類固醇之組合 |
| TW201617343A (zh) * | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物 |
| CN106083615B (zh) * | 2016-06-08 | 2019-03-08 | 山东省药学科学院 | 一种盐酸环喷托酯的制备方法 |
| US11274100B2 (en) | 2017-06-21 | 2022-03-15 | Daiichi Sankyo Company, Limited | EP300/CREBBP inhibitor |
| IL295255A (en) | 2020-02-03 | 2022-10-01 | Genzyme Corp | Methods for treating neurological symptoms associated with lysosomal storage diseases |
| CA3186766A1 (en) | 2020-07-24 | 2022-01-27 | Danielle Combessis | Pharmaceutical compositions comprising venglustat |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2168881A1 (en) * | 1972-01-25 | 1973-09-07 | Synthelabo | Tropanol 1-phenylcycloalkane carboxylic ester salts - spasmolytics and cholinergics |
| US4418202A (en) * | 1981-12-21 | 1983-11-29 | Emery Industries, Inc. | 2-Vinyl- and 2-ethylcyclopropane monocarboxylates |
| DD289411A7 (de) * | 1984-06-29 | 1991-05-02 | Arzneimittelwerk Dresden Gmbh,De | Verfahren zur herstellung eines antidos fuer phosphororganische verbindungen |
| IT1228293B (it) * | 1989-02-06 | 1991-06-07 | Angeli Inst Spa | Benzoderivati di composti eterociclici contenenti azoto. |
| US5086054A (en) * | 1990-07-31 | 1992-02-04 | Sri International | Novel arylcycloalkanepolyalkylamines |
| US5064850A (en) * | 1991-04-08 | 1991-11-12 | Marion Merrell Dow Inc. | Dihydro-3,3-diphenyl-5-(1H-pyrazol-1-ylmethyl-2(3H)-furanone and dihydro-5-((substituted-1H-pyrazol-1-yl)methyl)-3,3-diphenyl-2(3H)-furanone derivatives |
| US5817679A (en) * | 1993-04-01 | 1998-10-06 | University Of Virginia | 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands |
-
1997
- 1997-07-23 SK SK46-99A patent/SK4699A3/sk unknown
- 1997-07-23 CN CN97196892A patent/CN1226886A/zh active Pending
- 1997-07-23 EE EEP199900034A patent/EE9900034A/xx unknown
- 1997-07-23 NZ NZ333798A patent/NZ333798A/xx unknown
- 1997-07-23 JP JP10508739A patent/JP2000515881A/ja active Pending
- 1997-07-23 US US09/230,164 patent/US6124354A/en not_active Expired - Fee Related
- 1997-07-23 KR KR1019997000803A patent/KR20000029703A/ko not_active Application Discontinuation
- 1997-07-23 EP EP97934832A patent/EP0923536A1/en not_active Withdrawn
- 1997-07-23 IL IL12809697A patent/IL128096A0/xx unknown
- 1997-07-23 BR BR9710614-3A patent/BR9710614A/pt unknown
- 1997-07-23 AU AU37905/97A patent/AU724563B2/en not_active Ceased
- 1997-07-23 CA CA002261692A patent/CA2261692A1/en not_active Abandoned
- 1997-07-23 PL PL97331384A patent/PL331384A1/xx unknown
- 1997-07-23 TR TR1999/00185T patent/TR199900185T2/xx unknown
- 1997-07-23 WO PCT/SE1997/001310 patent/WO1998004517A1/en not_active Application Discontinuation
-
1999
- 1999-01-25 NO NO990335A patent/NO990335L/no not_active Application Discontinuation
- 1999-02-25 BG BG103207A patent/BG103207A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO990335L (no) | 1999-03-29 |
| BG103207A (en) | 1999-10-29 |
| NZ333798A (en) | 2000-08-25 |
| WO1998004517A1 (en) | 1998-02-05 |
| SK4699A3 (en) | 2000-04-10 |
| IL128096A0 (en) | 1999-11-30 |
| PL331384A1 (en) | 1999-07-05 |
| AU724563B2 (en) | 2000-09-28 |
| CA2261692A1 (en) | 1998-02-05 |
| BR9710614A (pt) | 2000-01-11 |
| JP2000515881A (ja) | 2000-11-28 |
| AU3790597A (en) | 1998-02-20 |
| CN1226886A (zh) | 1999-08-25 |
| EP0923536A1 (en) | 1999-06-23 |
| KR20000029703A (ko) | 2000-05-25 |
| TR199900185T2 (xx) | 1999-04-21 |
| NO990335D0 (no) | 1999-01-25 |
| US6124354A (en) | 2000-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
| EE03680B1 (et) | Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid | |
| ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
| DE69618587D1 (de) | Chinazoline und pharmazeutische zusammensetzungen | |
| DK0938345T3 (da) | Vandbaseret farmaceutisk sammensætning | |
| EE9900147A (et) | Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena | |
| ID18352A (id) | Komposisi-komposisi farmasi | |
| NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
| KR100547921B1 (ko) | 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물 | |
| EE200000037A (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena | |
| EE05000B1 (et) | 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid | |
| EE03825B1 (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
| EE9900034A (et) | Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine | |
| EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| BR9509688A (pt) | Composto e composição farmacêutica | |
| EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine | |
| ID16781A (id) | Formulasi-formulasi farmasi | |
| BR9507768A (pt) | Composição farmacêutica | |
| ID18698A (id) | Komposisi farmasi | |
| ITMI942166A0 (it) | Composizioni farmaceutiche miorilassanti | |
| ITMI951417A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
| NZ329271A (en) | 4-benzyl-piperidin-4-ol derivatives, preparation and pharmaceutical compositions thereof | |
| ITMI962628A0 (it) | Composizione farmaceutica | |
| FI962738A (fi) | Farmaseuttiset koostumukset | |
| BR9505130A (pt) | Composto e composiçao farmacêutica |